0001209191-17-037298.txt : 20170602 0001209191-17-037298.hdr.sgml : 20170602 20170602163958 ACCESSION NUMBER: 0001209191-17-037298 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170601 FILED AS OF DATE: 20170602 DATE AS OF CHANGE: 20170602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDNAX, INC. CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 263667538 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 FORMER COMPANY: FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC DATE OF NAME CHANGE: 19950801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clark David A. CENTRAL INDEX KEY: 0001443082 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 17888561 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-01 0 0000893949 MEDNAX, INC. MD 0001443082 Clark David A. 1301 CONCORD TERRACE SUNRISE FL 33323 0 1 0 0 Pres. Mednax Natl Med Group Common Stock 2017-06-01 4 A 0 15277 0.00 A 35302 D Common Stock 2017-06-01 4 S 0 10202 54.9932 D 25100 D Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Sales made pursuant to Reporting Person's 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in fifty-three (53) separate transactions with prices ranging from $54.16 to $55.39 for an average weighted sales price of $54.9932. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Dominic J. Andreano, Attorney-in-Fact 2017-06-02